• This record comes from PubMed

Survival trends in hematological malignancies in the Nordic countries through 50 years

. 2022 Nov 07 ; 12 (11) : 150. [epub] 20221107

Language English Country United States Media electronic

Document type Letter, Research Support, Non-U.S. Gov't

Links

PubMed 36336699
PubMed Central PMC9637692
DOI 10.1038/s41408-022-00728-z
PII: 10.1038/s41408-022-00728-z
Knihovny.cz E-resources

[Image: see text]

See more in PubMed

Yang B, Yu R, Cai L, Bin G, Chen H, Zhang H, et al. Haploidentical versus matched donor stem cell transplantation for patients with hematological malignancies: a systemic review and meta-analysis. Bone Marrow Transpl. 2019;54:99–122. doi: 10.1038/s41409-018-0239-9. PubMed DOI

Evens AM, Hutchings M, Diehl V. Treatment of Hodgkin lymphoma: the past, present, and future. Nat Clin Pr Oncol. 2008;5:543–56.. doi: 10.1038/ncponc1186. PubMed DOI

Pui CH, Nichols KE, Yang JJ. Somatic and germline genomics in paediatric acute lymphoblastic leukaemia. Nat Rev Clin Oncol. 2019;16:227–40. doi: 10.1038/s41571-018-0136-6. PubMed DOI

Pulte D, Jansen L, Brenner H. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century. Blood Cancer J. 2020;10:56. doi: 10.1038/s41408-020-0323-4. PubMed DOI PMC

Shallis RM, Wang R, Davidoff A, Ma X, Podoltsev NA, Zeidan AM. Epidemiology of the classical myeloproliferative neoplasms: the four corners of an expansive and complex map. Blood Rev. 2020;42:100706. doi: 10.1016/j.blre.2020.100706. PubMed DOI

Pukkala E, Engholm G, Hojsgaard Schmidt LK, Storm H, Khan S, Lambe M, et al. Nordic Cancer Registries - an overview of their procedures and data comparability. Acta Oncol. 2018;57:440–55. doi: 10.1080/0284186X.2017.1407039. PubMed DOI

Hemminki K, Försti A, Hansson M. Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016. Sci Rep. 2021;11:17272. doi: 10.1038/s41598-021-96804-8. PubMed DOI PMC

Lundberg FE, Andersson TM, Lambe M, Engholm G, Mørch LS, Johannesen TB, et al. Trends in cancer survival in the Nordic countries 1990–2016: the NORDCAN survival studies. Acta Oncol. 2020;59:1266–74. doi: 10.1080/0284186X.2020.1822544. PubMed DOI

Hou JZ, Ye JC, Pu JJ, Liu H, Ding W, Zheng H, et al. Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting. J Hematol Oncol. 2021;14:66. doi: 10.1186/s13045-021-01077-3. PubMed DOI PMC

Cordoba R, Eyre TA, Klepin HD, Wildes TM, Goede V. A comprehensive approach to therapy of haematological malignancies in older patients. Lancet Haematol. 2021;8:e840–e52. doi: 10.1016/S2352-3026(21)00241-6. PubMed DOI

Eichenauer DA, Aleman BMP, André M, Federico M, Hutchings M, Illidge T, et al. Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol: Off J Eur Soc Med Oncol. 2018;29(Suppl 4):iv19–iv29. doi: 10.1093/annonc/mdy080. PubMed DOI

Tallman MS, Wang ES, Altman JK, Appelbaum FR, Bhatt VR, Bixby D, et al. Acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2019;17:721–49. doi: 10.6004/jnccn.2019.0028. PubMed DOI

Eichhorst B, Robak T, Montserrat E, Ghia P, Niemann CU, Kater AP, et al. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol: Off J Eur Soc Med Oncol. 2021;32:23–33. doi: 10.1016/j.annonc.2020.09.019. PubMed DOI

Hemminki K, Försti A, Houlston R, Sud A. Epidemiology, genetics and treatment of multiple myeloma and precursor diseases. Int J Cancer. 2021;149:1980–96. doi: 10.1002/ijc.33762. PubMed DOI PMC

Bower H, Björkholm M, Dickman PW, Höglund M, Lambert PC, Andersson TM. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population. J Clin Oncol: Off J Am Soc Clin Oncol. 2016;34:2851–7. doi: 10.1200/JCO.2015.66.2866. PubMed DOI

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...